Special Issue "Adenosine Receptors"
Deadline for manuscript submissions: closed (10 May 2017)
Prof. Dr. Francisco Ciruela
Departament Patologiai Terapèutica Experimental, Facultat de Medicina-Bellvitge, IDIBELL, Universitat de Barcelona. Av. FeixaLlarga, s/n, 08907 L’Hospitalet de Llobregat, Spain
Website | E-Mail
Interests: G protein-coupled receptors; adenosine receptors; neuropharmacology; neurological diseases; allosteric modulation; receptor-receptor interactions; psychiatric diseases
Prof. Dr. Eddy Sotelo
Centro Singular de Investigación en Quı́mica Biológica y Materiales Moleculares (CIQUS) and Departamento de Quı́mica Orgánica, Facultad de Farmacia, Universidad de Santiago de Compostela, E-15782 Santiago de Compostela, Spain
Interests: medicinal chemistry; adenosine receptors; GPCRs; multicomponent reactions; GPCR-oligomerization; chemical probes; allosteric modulation; multi-target drug discovery; hit identification
Adenosine is a well-known neuromodulator in the central nervous system and has effects on other tissues like immune or circulatory systems. Its physiological actions are exerted through G protein-coupled adenosine receptors (AR), which, in turn, are expressed in a large variety of cells. Interestingly, selective agonists and antagonists for all four AR subtypes have been developed and its diagnostic and therapeutic utility is being pursued.
Using AR as a paradigm of purinergic GPCRs, in this Special Issue, we intended to provide the reader with the recent developments in AR ligands. Thus, the submissions of papers describing new molecules showing activity through AR are welcome. In addition, manuscripts describing new AR-based chemical tools or approaches for the study of adenosine function, prospective analysis for the therapeutic future of AR ligands, and reviews will be also taken into consideration. Finally, authors are encouraged to propose topics that will be evaluated accordingly. Overall, we hope that this timely focused issue summarizing our current knowledge on adenosine receptors ligands will be of interest to a wide range of readers of the journal.
Prof. Dr. Francisco Ciruela
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Molecules is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1800 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- Medicinal Chemistry
- Adenosine Receptor Ligands
- G protein-coupled receptors
- Clinical trials
- Allosteric modulator